“Black Box” warnings added to antidepressants might have contributed to an increase in suicide attempts and deaths among young people, a new evidence review claims. The warnings say that antidepressants might be associated with suicidal thoughts and behaviors in children and teens, and were intended to prompt doctors to more closely monitor young people prescribed…  read on >  read on >

The health benefits of fluoridated drinking water may be waning as Americans increasingly turn to using toothpastes and mouthwashes that already contain fluoride, a new review suggests. The research, published Thursday in the Cochrane Database of Systematic Reviews, came to that conclusion after analyzing more than 157 studies that compared tooth decay in kids living in…  read on >  read on >

THURSDAY, Oct. 3, 2024 (HeathDay News) — Moms-to-be have long known about breast milk’s multiple benefits. Now, a global study confirms that antibodies passed from to baby in breast milk can indeed shield against disease. Immune system antibodies against one common infection, rotavirus, were especially protective, said a team from the University of Rochester in…  read on >  read on >

Most Americans are eating their way to inflammation that puts them at risk of cancer, heart disease and other serious health problems, a new study shows. “Overall, 57% of U.S. adults have a pro-inflammatory diet and that number was higher for Black Americans, men, younger adults and people with lower education and income,” said lead…  read on >  read on >

Following the historic destruction of Hurricane Helene, many Americans must now return to their mangled homes and begin the heartbreaking task of clean-up. After making landfall in Florida near Tallahassee as a ferocious Cat 4 storm on Thursday, Helene caused record-breaking storm surges in Tampa, flash flooding in Atlanta and power outages, massive flooding and…  read on >  read on >

An experimental monoclonal antibody treatment appears to ease the digestive disorder ulcerative colitis in patients who’ve failed other medications, a new trial shows. The treatment, tulisokibart, spurred remission of symptoms in more than a quarter of patients, compared to only 1.5% of those taking a placebo, an international group of researchers reported Sept. 26 in…  read on >  read on >